Origin of clear cell carcinoma: nature or nurture?
letter
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
Endometrioid and clear cell ovarian carcinomas may arise from secretory and ciliated cells, respectively, as indicated by differential cell marker expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A rare but serious complication of endometriosis is the development of carcinoma, and clear cell and endometrioid carcinomas of the ovary are the two most common malignancies which arise from endometriosis. They are distinct diseases, characterized by unique morphologies, immunohistochemical profiles, and responses to treatment. However, both arise in endometriosis and can share common mutations. The overlapping mutational profiles of clear cell and endometrioid carcinomas suggest that their varied histologies may be due to a different cell of origin which gives rise to each type of cancer. Cochrane and colleagues address this question in a recent article in this journal. They show that a marker of ovarian clear cell carcinoma, cystathionine gamma lyase, is expressed in ciliated cells. Similarly, they show that markers of secretory cells (estrogen receptor and methylenetetrahydrofolate dehydrogenase 1) are expressed in ovarian endometrioid carcinoma. Taken together, they suggest that endometrioid and clear cell carcinomas arise from cells related to secretory and ciliated cells, respectively. We discuss Cochrane et al's work in the context of other efforts to determine the cell of origin of gynecological malignancies, with an emphasis on recent developments and challenges unique to the area. These limitations complicate our interpretation of tumor differentiation; does it reflect nature imposed by a specific cell of origin or nurture, by either mutation(s) or environment? Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Activation of mutated K‐ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis via openalex
- Cancer-Associated Mutations in Endometriosis without Cancer via openalex
- Distinct β-Catenin and PIK3CA Mutation Profiles in Endometriosis-Associated Ovarian Endometrioid and Clear Cell Carcinomas via openalex
- Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis via openalex
- KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- W2511058727 via openalex
- W2529501230 via openalex
- W1491756000 via openalex
- W2733225411 via openalex
- W2001541544 via openalex
- W2002604331 via openalex
- W2073302269 via openalex
- W2094533199 via openalex
- W2130344626 via openalex
Cited by (7)
- Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making 2026
- Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis 2025
- Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes 2023
- Sensitive New Assay System for Serum <i>Wisteria floribunda</i> Agglutinin-Reactive Ceruloplasmin That Distinguishes Ovarian Clear Cell Carcinoma from Endometrioma 2022
- How Benign is Endometriosis: Multi-Scale Interrogation of Documented Evidence 2019
- The Endometriotic Tumor Microenvironment in Ovarian Cancer 2018
- Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis 2018
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:07.505861+00:00
- unpaywall
- last seen: 2026-06-06T02:00:05.402940+00:00
License: CC0
· commercial use OK